New Nordic - About the company
New Nordic is a public company based in Denmark, founded in 1923. It operates as a Manufacturer of drugs for diabetes, obesity, hemophilia, and hormone therapy. New Nordic has raised $145K in funding. The company has 1947 active competitors, including 100 funded and 206 that have exited. Its top competitors include companies like AbbVie, Novartis and Gilead.
Company Details
Manufacturer of drugs for diabetes, obesity, hemophilia, and hormone therapy. It is focused on defeating diabetes and other serious chronic conditions such as rare bleeding disorders, and growth hormone-related disorders. The company makes several drugs under various brand names, including Levemir, NovoLog, Novolin R, NovoSeven, NovoEight, and Victoza. In 2022, the company recorded annual revenues of $26.32B and a net profit of $8.54B.
- Website
- www.novonordisk.com/
- Social
- Phone Number
- +45 **********
- Registered Address
- NXT 2, 1 & 2nd Floor, Embassy Manyata Business Park, Nagavara Village, Kasaba Hobli, Venkateshapura, Bangalore, Bangalore North, Karnataka, India, 560045
Key Metrics
Founded Year
1923
Location
Stage
Public
Total Funding
$145K in 9 rounds
Latest Funding Round
Investors
Ranked
38th among 1947 active competitors
Annual Revenue
$1B+ as on Dec 31, 2024
Employee Count
62,149 as on Aug 31, 2026
Investment & Acquisitions
Exit Details
Public
Legal entities associated with New Nordic
New Nordic is associated with 4 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
NOVO NORDISK REGION EUROPE A/S CIN: 26236266 , Denmark, Active | Sep 13, 2001 | - | - | |
NOVO NORDISK SERVICE CENTRE (INDIA) PRIVATE LIMITED CIN: U74990KA2011PTC057129 , India, Active | Feb 15, 2011 | ₹1,000+ Cr (As on Mar 31, 2025) | 4539 (As on Aug 01, 2025) | |
NOVO NORDISK INDIA PRIVATE LIMITED CIN: U24111KA1994PTC015194 , India, Active | Feb 07, 1994 | ₹1,000+ Cr (As on Mar 31, 2025) | 1488 (As on Feb 29, 2024) | |
Novo Nordisk A/s CIN: 24256790 , Denmark, Active | $1B+ (As on Dec 31, 2024) | 29288 (As on Dec 31, 2024) |
New Nordic's IPO details
New Nordic got listed on May 01, 1981.
Click here to take a look at New Nordic's IPO in detail
Sign up to download New Nordic's company profile
New Nordic's funding and investors
New Nordic has raised a total funding of $145K over 9 rounds. Its first funding round was on 1984. Its latest funding round was a Grant (prize money) round on Mar 01, 2022 for $*****. 1 investor participated in its latest round. New Nordic has 11 institutional investors.
Here is the list of recent funding rounds of New Nordic:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 01, 2022 | 5890773 | Grant (prize money) | 1565824 | 3120710 | 8204834 | 1583011 |
Jan 01, 2021 | 7471265 | Grant (prize money) | 5314091 | 8484130 | 7983409 | |
Jan 01, 2020 | 2799720 | Grant (prize money) | 4147197 | 8427215 | 8526961 |
Access funding benchmarks and valuations. Sign up today!View details of New Nordic's funding rounds and investors
New Nordic's founders and board of directors
Founder? Claim ProfileNew Nordic's Board of Directors
New Nordic's board has 12 active members. Helge Lund and Henrik Poulsen are part of team and Kasim Kutay, Christina Law, Elisabeth Dahl Christensen, Andreas Fibig, Liselotte Hyveled, Martin Mackay, Laurence Debroux, Mette Bøjer Jensen, Thomas Rantzau and Sylvie Grégoire are independent board members.Here is the list of New Nordic's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
dbpolbc | Team | - | Current | 2y 2m |
oqzxq{g | Team | - | Current | 6y 8m |
Independent board member | - | Current | 9y 6m | |
iylxhwh | Independent board member | - | Current | 9y 8m |
bwpizwy | Independent board member | - | Current | 1y 1m |
cfhbfcd | Independent board member | - | Current | 3y 4m |
nsgzbxn | Independent board member | - | Current | 8y 6m |
pfnxbpc | Independent board member | - | Current | 4y 4m |
wzaodmd | Independent board member | - | Current | 5y 4m |
djpiwrr | Independent board member | - | Current | 5y 7m |
lnxrdpf | Independent board member | - | Current | 3y 8m |
cru{huq | Independent board member | - | Current | 7y 4m |
New Nordic's employee count trend
New Nordic has 62,149 employees as of Aug 26. Here is New Nordic's employee count trend over the years:
Uncover New Nordic's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
New Nordic's Competitors and alternates
Top competitors of New Nordic include AbbVie, Novartis and Gilead. Here is the list of Top 10 competitors of New Nordic, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 83/100 | |
2nd | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 81/100 | |
3rd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 81/100 | |
4th | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 79/100 | |
5th |  AstraZeneca 1999, Cambridge (United Kingdom), Public | Developer of pharmaceutical medicines for oncology and various chronic diseases | - | 76/100 | |
6th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 75/100 | |
7th |  Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 74/100 | |
8th |  Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | 71/100 | |
9th |  Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 70/100 | |
10th | Genentech 1976, San Francisco (United States), Acquired | R&D company focused on manufacturing drugs for multiple therapeutic areas | $72.5M | 68/100 | |
38th |  New Nordic 1923, Denmark, Public | Manufacturer of drugs for diabetes, obesity, hemophilia, and hormone therapy | $145K | 60/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on New Nordic's competitors? Click here to see the top ones
New Nordic's Investments and acquisitions
New Nordic has made 22 investments in companies including Orbis Medicines and Aspect Biosystems. New Nordic has also acquired 13 companies including Akero Therapeutics and Cardior Pharmaceuticals.Here is the list of investments & acquisitions:Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Sep 17, 2026 | Investments | 2022 | Copenhagen (Denmark) | |
Oct 09, 2025 | Acquisition | 2017 | San Francisco (United States) | |
Jan 08, 2025 | Investments | 2013 | Vancouver (Canada) |
Want to know more about where corporates are investing? Sign up today!See all investments and acquisitions by New Nordic
Reports related to New Nordic
Here is the latest report on New Nordic's sector:
News related to New Nordic
Filter this listMedia has covered New Nordic for a total of 380 events in the last 1 year, 189 of them have been about company updates and 31 about partnerships.
•
•
Novo Nordisk: After A 70+% Drop, It's A Great Investment (NYSE:NVO)Seeking Alpha•Sep 29, 2026•New Nordic
•
Novo Nordisk A/S and Hengrui Pharma Enter Exclusive License Agreement for Oral GLP-1/GIP AgonistGlobeNewswire•Sep 29, 2026•New Nordic, Hengrui, com.cn
•
•
•
Dozens Sue GLP-1 Drug Companies Over Alleged Vision LossAl Jazeera Media Network•Sep 22, 2026•New Nordic, Lilly
•
Novo Nordisk and UNICEF Expand Partnership to Support Healthier Start for Over 80 Million ChildrenGlobeNewswire•Sep 22, 2026•New Nordic, UNICEF
•
Novo's CagriSema Shows Superior Weight Loss vs. Tirzepatide in Phase 3 TrialsGlobeNewswire•Sep 21, 2026•New Nordic
•
Novo says its next-gen obesity drug tops Lilly rival in late-stage studyReuters•Sep 21, 2026•New Nordic
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about New Nordic
Explore our recently published companies
- Nicerobotcreative - Unfunded company
- Mang00 - 2018 founded, Unfunded company
- Elicohenagency Webflow - Unfunded company
- Advanced Mechatronics - Germany based, Unfunded company
- Sensor-Control - Germany based, Unfunded company
- Edbspa - Unfunded company
